|
Volumn 41, Issue 3, 2001, Pages 166-173
|
Chemotherapy-associated myelosuppression in gynecological oncology;Chemotherapieassoziierte myelosuppression in der gynäkologischen onkologie
|
Author keywords
Adverse effects; Breast neoplasm; Chemotherapy; Cytostatic treatment; Myelosuppression; Ovarian neoplasm
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
CYCLOPHOSPHAMIDE;
CYTOSTATIC AGENT;
DOCETAXEL;
EPIRUBICIN;
FLUOROURACIL;
HEMOGLOBIN;
METHOTREXATE;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
ADULT;
ADVANCED CANCER;
AGED;
AREA UNDER THE CURVE;
ARTICLE;
BONE MARROW SUPPRESSION;
BREAST CARCINOMA;
CANCER COMBINATION CHEMOTHERAPY;
CANCER STAGING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOPENIA;
CYTOSTASIS;
ERYTHROCYTE TRANSFUSION;
ERYTHROPOIESIS;
FEMALE;
GYNECOLOGY;
HUMAN;
LEUKOCYTE COUNT;
LEUKOPENIA;
LEUKOPOIESIS;
MAJOR CLINICAL STUDY;
ONCOLOGY;
OVARY CARCINOMA;
THROMBOCYTE COUNT;
THROMBOCYTOPOIESIS;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BONE MARROW;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
CISPLATIN;
COBALT RADIOISOTOPES;
COMBINED MODALITY THERAPY;
CYCLOPHOSPHAMIDE;
DATA INTERPRETATION, STATISTICAL;
ETOPOSIDE;
FEMALE;
FLUOROURACIL;
HEMATOPOIESIS;
HUMANS;
LEUKOPOIESIS;
LYMPH NODE EXCISION;
LYMPHATIC METASTASIS;
MASTECTOMY, SEGMENTAL;
METHOTREXATE;
MIDDLE AGED;
OVARIAN NEOPLASMS;
PLATELET COUNT;
RADIOISOTOPE TELETHERAPY;
RADIOTHERAPY DOSAGE;
|
EID: 18244372738
PISSN: 10188843
EISSN: None
Source Type: Journal
DOI: 10.1159/000049471 Document Type: Article |
Times cited : (6)
|
References (23)
|